中文产业新闻精选评分78Chinese source
信达生物替妥尤单抗N01注射液非活动性甲状腺眼病Ⅲ期阳性，眼球突出应答率达60.4%
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.